By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Rock Creek Pharmaceuticals, Inc. (Form 8-K) was posted on June 26, 2014.
The SIC code for this company is 2833, Medicinal Chemicals and Botanical Products.
There was one document filed with this form. The SEC file number is 0001144204-14-039841.
The contact information for this company is 4470 COX ROAD, SUITE 110, GLEN ALLEN VA 23060, 8045271970.
Our editors provided additional information about Form 8-K: This is the “current report” that is used to report the occurrence of any material events or corporate changes which are of importance to investors or security holders and previously have not been reported by the registrant. It provides more current information on certain specified events than would Forms 10-Q or 10-K.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/776008/0001144204-14-039841-index.html.
Keywords for this news article include: Pharmaceutical Companies, Rock Creek Pharmaceuticals Inc., Chemistry, SEC Filing, Medicinal Chemicals and Botanical Products.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC